Vivo Capital’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Vivo Capital’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-421,635	Closed	-$5.18M	–	50
2022 Q4	$5.18M	Buy	421,635 +72,398	+21%	+$1.73M	0.6%	33
2022 Q3	$11.5M	Buy	+349,237	New	+$9.87M	1.27%	22

Vivo Capital's CINC Position: Q1 2023 in Review

Vivo Capital sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 421,635 shares — an estimated $5.18M sold.

Vivo Capital first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $11.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Vivo Capital reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Vivo Capital sold 421,635 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $5.18M.
Vivo Capital first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Vivo Capital's CinCor Pharma, Inc. Common Stock position peaked at $11.5M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Vivo Capital's 13F filing for Q1 2023, filed 15 May 2023.